A citation-based method for searching scientific literature

Anna L Krämer, Angelina Riederer, Federico Fracassi, Felicitas S Boretti, Nadja S Sieber-Ruckstuhl, Thomas A Lutz, Barbara Contiero, Eric Zini, Claudia E Reusch. J Vet Intern Med 2020
Times Cited: 3







List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Systematic review of feline diabetic remission: separating fact from opinion.
Ruth Gostelow, Yaiza Forcada, Thomas Graves, David Church, Stijn Niessen. Vet J 2014
22
100

Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats.
Eric Zini, Elena Salesov, Perrine Dupont, Laura Moretto, Barbara Contiero, Thomas A Lutz, Claudia E Reusch. J Vet Intern Med 2018
6
66

Glucose variability.
F John Service. Diabetes 2013
123
66


Evaluation of a new portable glucose meter designed for the use in cats.
E Zini, S Moretti, F Tschuor, C E Reusch. Schweiz Arch Tierheilkd 2009
40
66

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
Bernard Zinman, Steven P Marso, Neil R Poulter, Scott S Emerson, Thomas R Pieber, Richard E Pratley, Martin Lange, Kirstine Brown-Frandsen, Alan Moses, Ann Marie Ocampo Francisco,[...]. Diabetologia 2018
85
66


2018 AAHA Diabetes Management Guidelines for Dogs and Cats.
Ellen Behrend, Amy Holford, Patty Lathan, Renee Rucinsky, Rhonda Schulman. J Am Anim Hosp Assoc 2018
32
66

Rebound hyperglycaemia in diabetic cats.
Kirsten Roomp, Jacquie Rand. J Feline Med Surg 2016
3
33

Remission of diabetes mellitus in cats cannot be predicted by the arginine stimulation test.
F Tschuor, E Zini, S Schellenberg, M Wenger, K Kaufmann, D Furrer, T A Lutz, C E Reusch. J Vet Intern Med 2011
10
33

Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh, Jae Hyeon Kim. Diabetes Metab J 2015
155
33

Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.
Kristine B Degn, Birgitte Brock, Claus B Juhl, Christian B Djurhuus, Jaime Grubert, Dennis Kim, Jenny Han, Kristin Taylor, Mark Fineman, Ole Schmitz. Diabetes 2004
200
33

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
33

Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial.
Ting-Ting Yin, Yan Bi, Ping Li, Shan-Mei Shen, Xiao-Lu Xiong, Li-Jun Gao, Can Jiang, Yan Wang, Wen-Huan Feng, Da-Long Zhu. Diabetes Ther 2018
11
33

Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus.
M A Scuderi, M Ribeiro Petito, S Unniappan, C Waldner, S Mehain, C J McMillian, E C Snead. Domest Anim Endocrinol 2018
4
33

New incretin hormonal therapies in humans relevant to diabetic cats.
Claudia E Reusch, Isabelle Padrutt. Vet Clin North Am Small Anim Pract 2013
3
33

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.
E L Lim, K G Hollingsworth, B S Aribisala, M J Chen, J C Mathers, R Taylor. Diabetologia 2011
561
33




International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
668
33




Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus.
A Riederer, E Zini, E Salesov, F Fracassi, I Padrutt, K Macha, T M Stöckle, T A Lutz, C E Reusch. J Vet Intern Med 2016
12
33



Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
D G Parkes, R Pittner, C Jodka, P Smith, A Young. Metabolism 2001
211
33

Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring.
David Rodbard, Timothy Bailey, Lois Jovanovic, Howard Zisser, Roy Kaplan, Satish K Garg. Diabetes Technol Ther 2009
96
33


The GLP-1 mimetic exenatide potentiates insulin secretion in healthy cats.
C Gilor, T K Graves, S Gilor, T K Ridge, M Rick. Domest Anim Endocrinol 2011
21
33

Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial.
Juan P Frías, Samer Nakhle, James A Ruggles, Sergey Zhuplatov, Eric Klein, Rong Zhou, Poul Strange. Diabetes Obes Metab 2017
20
33

Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.
John M Lachin, Saul Genuth, David M Nathan, Bernard Zinman, Brandy N Rutledge. Diabetes 2008
287
33


A once-monthly GLP-1 receptor agonist for treatment of diabetic cats.
E L Schneider, R Reid, D G Parkes, T A Lutz, G W Ashley, D V Santi. Domest Anim Endocrinol 2020
3
33



Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study.
Cheng-Chieh Lin, Chun-Pai Yang, Chia-Ing Li, Chiu-Shong Liu, Ching-Chu Chen, Wen-Yuan Lin, Kai-Lin Hwang, Sing-Yu Yang, Tsai-Chung Li. BMC Med 2014
49
33


Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus.
Nina Alt, Saskia Kley, Michael Haessig, Claudia E Reusch. J Am Vet Med Assoc 2007
21
33

Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes.
Guillermo E Umpierrez, Boris P Kovatchev. Am J Med Sci 2018
32
33

Glucose variability: An emerging target for the treatment of diabetes mellitus.
Simona Frontoni, Paolo Di Bartolo, Angelo Avogaro, Emanuele Bosi, Giuseppe Paolisso, Antonio Ceriello. Diabetes Res Clin Pract 2013
89
33

Pharmacology of the glucagon-like peptide-1 analog exenatide extended-release in healthy cats.
A J Rudinsky, C A Adin, S Borin-Crivellenti, P Rajala-Schultz, M J Hall, C Gilor. Domest Anim Endocrinol 2015
14
33

Effect of exenatide after short-time intensive insulin therapy on glycaemic remission maintenance in type 2 diabetes patients: a randomized controlled trial.
Xiulin Shi, Yalin Shi, Ning Chen, Mingzhu Lin, Weijuan Su, Huijie Zhang, Changqin Liu, Haiqu Song, Fangsen Xiao, Peiying Huang,[...]. Sci Rep 2017
4
33

Remission of diabetes mellitus in cats with diabetic ketoacidosis.
N S Sieber-Ruckstuhl, S Kley, F Tschuor, E Zini, S Ohlerth, F S Boretti, C E Reusch. J Vet Intern Med 2008
26
33

Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargine.
Anthony L McCall, Daniel J Cox, Robert Brodows, John Crean, Don Johns, Boris Kovatchev. Diabetes Technol Ther 2009
34
33

Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
Suk Chon, Yun Jung Lee, Gemma Fraterrigo, Paolo Pozzilli, Moon Chan Choi, Mi-Kwang Kwon, Sang Ouk Chin, Sang Youl Rhee, Seungjoon Oh, Young-Seol Kim,[...]. Diabetes Technol Ther 2013
21
33

Exenatide improves glycemic variability assessed by continuous glucose monitoring in subjects with type 2 diabetes.
Concetta Irace, Raffaella Fiorentino, Claudio Carallo, Faustina Scavelli, Agostino Gnasso. Diabetes Technol Ther 2011
21
33

Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data.
Yongming Qu, Scott J Jacober, Qianyi Zhang, Linda L Wolka, J Hans DeVries. Diabetes Technol Ther 2012
84
33

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).
Hannele Yki-Järvinen, Richard Bergenstal, Monika Ziemen, Marek Wardecki, Isabel Muehlen-Bartmer, Emmanuelle Boelle, Matthew C Riddle. Diabetes Care 2014
181
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.